US Stock MarketDetailed Quotes

CRBP Corbus Pharmaceuticals

Watchlist

42.8000
+1.3000+3.13%

Close May 31 16:00 ET

457.39MMarket Cap-6202P/E (TTM)

Corbus Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

-44.37%9.62M

29.40%45.08M

-6.42%10.1M

15.97%9.49M

11.57%8.19M

103.08%17.3M

-38.75%34.84M

7.99%10.8M

-41.45%8.18M

-56.41%7.34M

Selling and administrative expenses

-1.21%3.86M

-25.61%13.91M

-31.42%3.12M

-27.88%2.94M

-18.60%3.94M

-25.28%3.91M

-8.45%18.7M

7.54%4.55M

-22.81%4.07M

-13.14%4.84M

-General and administrative expense

-1.21%3.86M

-25.61%13.91M

-31.42%3.12M

-27.88%2.94M

-18.60%3.94M

-25.28%3.91M

-8.45%18.7M

7.54%4.55M

-22.81%4.07M

-13.14%4.84M

Research and development costs

-56.97%5.76M

93.15%31.17M

11.81%6.98M

59.45%6.55M

69.97%4.25M

307.41%13.39M

-55.72%16.14M

8.31%6.24M

-52.76%4.11M

-77.81%2.5M

Operating profit

44.37%-9.62M

-29.40%-45.08M

6.42%-10.1M

-15.97%-9.49M

-11.57%-8.19M

-103.08%-17.3M

37.78%-34.84M

-7.99%-10.8M

41.04%-8.18M

56.05%-7.34M

Net non-operating interest income expense

73.89%-177.02K

-37.14%-2.92M

-10.31%-707.01K

-40.87%-763.36K

-58.17%-775.59K

-47.75%-678.02K

-16.48%-2.13M

-63.97%-640.95K

-38.28%-541.89K

-22.23%-490.34K

Non-operating interest expense

----

40.87%763.36K

----

--541.89K

----

Total other finance cost

-73.89%177.02K

37.14%2.92M

----

58.17%775.59K

47.75%678.02K

16.48%2.13M

----

22.23%490.34K

Other net income (expense)

1,160.01%2.9M

163.17%3.4M

399.17%2.79M

439.23%198.03K

103.34%180.74K

149.92%230.24K

-144.17%-5.38M

334.71%558.72K

-100.48%-58.38K

-14,890.29%-5.42M

Gain on sale of security

-1,213.74%-8.11K

102.58%8.52K

-89.68%29.23K

85.66%-19.52K

99.08%-1.92K

100.27%728

-218.45%-330.59K

1,401.20%283.17K

-334.25%-136.09K

-209.61%-209.86K

Special income (charges)

----

--0

----

---5M

--0

---5M

-Less:Other special charges

----

--5M

--0

----

--5M

Other non- operating income (expenses)

1,167.54%2.91M

7,049.42%3.39M

901.54%2.76M

179.94%217.55K

187.53%182.66K

218.70%229.51K

-100.41%-48.77K

151.27%275.55K

-99.35%77.71K

8.32%-208.68K

Income before tax

61.12%-6.9M

-5.33%-44.6M

26.27%-8.02M

-14.48%-10.05M

33.70%-8.78M

-88.03%-17.74M

7.22%-42.35M

-6.03%-10.88M

-303.54%-8.78M

22.69%-13.25M

Income tax

Net income

61.12%-6.9M

-5.33%-44.6M

26.27%-8.02M

-14.48%-10.05M

33.70%-8.78M

-88.03%-17.74M

7.22%-42.35M

-6.03%-10.88M

-303.54%-8.78M

22.69%-13.25M

Net income continuous Operations

61.12%-6.9M

-5.33%-44.6M

26.27%-8.02M

-14.48%-10.05M

33.70%-8.78M

-88.03%-17.74M

7.22%-42.35M

-6.03%-10.88M

-303.54%-8.78M

22.69%-13.25M

Minority interest income

Net income attributable to the parent company

61.12%-6.9M

-5.33%-44.6M

26.27%-8.02M

-14.48%-10.05M

33.70%-8.78M

-88.03%-17.74M

7.22%-42.35M

-6.03%-10.88M

-303.54%-8.78M

22.69%-13.25M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

61.12%-6.9M

-5.33%-44.6M

26.27%-8.02M

-14.48%-10.05M

33.70%-8.78M

-88.03%-17.74M

7.22%-42.35M

-6.03%-10.88M

-303.54%-8.78M

22.69%-13.25M

Basic earnings per share

80.42%-0.83

-1.58%-10.31

31.42%-1.79

-7.58%-2.27

35.53%-2.05

-87.61%-4.24

8.97%-10.15

-8.75%-2.61

-251.67%-2.11

29.33%-3.18

Diluted earnings per share

80.42%-0.83

-1.58%-10.31

31.42%-1.79

-7.58%-2.27

35.53%-2.05

-87.61%-4.24

8.97%-10.15

-8.75%-2.61

-251.67%-2.11

29.33%-3.18

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-44.37%9.62M	29.40%45.08M	-6.42%10.1M	15.97%9.49M	11.57%8.19M	103.08%17.3M	-38.75%34.84M	7.99%10.8M	-41.45%8.18M	-56.41%7.34M
Selling and administrative expenses	-1.21%3.86M	-25.61%13.91M	-31.42%3.12M	-27.88%2.94M	-18.60%3.94M	-25.28%3.91M	-8.45%18.7M	7.54%4.55M	-22.81%4.07M	-13.14%4.84M
-General and administrative expense	-1.21%3.86M	-25.61%13.91M	-31.42%3.12M	-27.88%2.94M	-18.60%3.94M	-25.28%3.91M	-8.45%18.7M	7.54%4.55M	-22.81%4.07M	-13.14%4.84M
Research and development costs	-56.97%5.76M	93.15%31.17M	11.81%6.98M	59.45%6.55M	69.97%4.25M	307.41%13.39M	-55.72%16.14M	8.31%6.24M	-52.76%4.11M	-77.81%2.5M
Operating profit	44.37%-9.62M	-29.40%-45.08M	6.42%-10.1M	-15.97%-9.49M	-11.57%-8.19M	-103.08%-17.3M	37.78%-34.84M	-7.99%-10.8M	41.04%-8.18M	56.05%-7.34M
Net non-operating interest income expense	73.89%-177.02K	-37.14%-2.92M	-10.31%-707.01K	-40.87%-763.36K	-58.17%-775.59K	-47.75%-678.02K	-16.48%-2.13M	-63.97%-640.95K	-38.28%-541.89K	-22.23%-490.34K
Non-operating interest expense	----	----	----	40.87%763.36K	----	----	----	----	--541.89K	----
Total other finance cost	-73.89%177.02K	37.14%2.92M	----	----	58.17%775.59K	47.75%678.02K	16.48%2.13M	----	----	22.23%490.34K
Other net income (expense)	1,160.01%2.9M	163.17%3.4M	399.17%2.79M	439.23%198.03K	103.34%180.74K	149.92%230.24K	-144.17%-5.38M	334.71%558.72K	-100.48%-58.38K	-14,890.29%-5.42M
Gain on sale of security	-1,213.74%-8.11K	102.58%8.52K	-89.68%29.23K	85.66%-19.52K	99.08%-1.92K	100.27%728	-218.45%-330.59K	1,401.20%283.17K	-334.25%-136.09K	-209.61%-209.86K
Special income (charges)	----	--0	--0	--0	--0	----	---5M	--0	--0	---5M
-Less:Other special charges	----	----	----	----	----	----	--5M	--0	----	--5M
Other non- operating income (expenses)	1,167.54%2.91M	7,049.42%3.39M	901.54%2.76M	179.94%217.55K	187.53%182.66K	218.70%229.51K	-100.41%-48.77K	151.27%275.55K	-99.35%77.71K	8.32%-208.68K
Income before tax	61.12%-6.9M	-5.33%-44.6M	26.27%-8.02M	-14.48%-10.05M	33.70%-8.78M	-88.03%-17.74M	7.22%-42.35M	-6.03%-10.88M	-303.54%-8.78M	22.69%-13.25M
Income tax
Net income	61.12%-6.9M	-5.33%-44.6M	26.27%-8.02M	-14.48%-10.05M	33.70%-8.78M	-88.03%-17.74M	7.22%-42.35M	-6.03%-10.88M	-303.54%-8.78M	22.69%-13.25M
Net income continuous Operations	61.12%-6.9M	-5.33%-44.6M	26.27%-8.02M	-14.48%-10.05M	33.70%-8.78M	-88.03%-17.74M	7.22%-42.35M	-6.03%-10.88M	-303.54%-8.78M	22.69%-13.25M
Minority interest income
Net income attributable to the parent company	61.12%-6.9M	-5.33%-44.6M	26.27%-8.02M	-14.48%-10.05M	33.70%-8.78M	-88.03%-17.74M	7.22%-42.35M	-6.03%-10.88M	-303.54%-8.78M	22.69%-13.25M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	61.12%-6.9M	-5.33%-44.6M	26.27%-8.02M	-14.48%-10.05M	33.70%-8.78M	-88.03%-17.74M	7.22%-42.35M	-6.03%-10.88M	-303.54%-8.78M	22.69%-13.25M
Basic earnings per share	80.42%-0.83	-1.58%-10.31	31.42%-1.79	-7.58%-2.27	35.53%-2.05	-87.61%-4.24	8.97%-10.15	-8.75%-2.61	-251.67%-2.11	29.33%-3.18
Diluted earnings per share	80.42%-0.83	-1.58%-10.31	31.42%-1.79	-7.58%-2.27	35.53%-2.05	-87.61%-4.24	8.97%-10.15	-8.75%-2.61	-251.67%-2.11	29.33%-3.18
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall